Home
>
National Drug Code (NDC)
>
ANTARA
ANTARA - 27437-110-01 - (FENOFIBRATE)
Drug Information of ANTARA
| Product NDC: | 27437-110 |
| Proprietary Name: | ANTARA |
| Non Proprietary Name: | FENOFIBRATE |
| Active Ingredient(s): | 130 mg/1 & nbsp; FENOFIBRATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ANTARA
| Product NDC: | 27437-110 |
| Labeler Name: | LUPIN PHARMA |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021695 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090925 |
Package Information of ANTARA
| Package NDC: | 27437-110-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (27437-110-01) |
NDC Information of ANTARA
| NDC Code | 27437-110-01 |
| Proprietary Name | ANTARA |
| Package Description | 100 CAPSULE in 1 BOTTLE (27437-110-01) |
| Product NDC | 27437-110 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | FENOFIBRATE |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20090925 |
| Marketing Category Name | NDA |
| Labeler Name | LUPIN PHARMA |
| Substance Name | FENOFIBRATE |
| Strength Number | 130 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [Chemical/Ingredient] |
